Revenue - Additional Information (Details) - USD ($)		3 Months Ended		12 Months Ended		39 Months Ended
	Sep. 19, 2018	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Apr. 17, 2018
Deferred Revenue Arrangement [Line Items]
Revenue		$ 4,282,586	$ 5,435,444
Grants receivable							$ 7,400,000
BARDA | Plan
Deferred Revenue Arrangement [Line Items]
Proceeds from funding agreement	$ 4,600,000
BARDA | Forecast
Deferred Revenue Arrangement [Line Items]
Proceeds from funding agreement						$ 3,000,000
Research And Development Arrangement September 19, 2018
Deferred Revenue Arrangement [Line Items]
Revenue		8,223,000
Royalty and licensing revenue
Deferred Revenue Arrangement [Line Items]
Revenue		4,198,500	3,746,250
Grant
Deferred Revenue Arrangement [Line Items]
Revenue		75,800	1,600,000
Grant | Forecast
Deferred Revenue Arrangement [Line Items]
Revenue				$ 1,800,000	$ 5,600,000
Adapt | Royalty and licensing revenue
Deferred Revenue Arrangement [Line Items]
Revenue		$ 4,200,000	$ 3,700,000